Kathleen Hurley is the founder of Sage Inc., a tech company that offers SMB businesses infrastructure solutions and next-gen technology. As data becomes everything to everybody, it’s crucial to ...

Artificial intelligence is no longer an emerging technology—it is an embedded reality shaping the way we live, govern and do business. From predictive healthcare to autonomous defense systems, AI is ...

The maintenance of pension scheme records has not kept pace with the digital age, warns Heka Global’s Max Lack. According to recent research from Lane Clark and Peacock (LCP), fewer than four in 10 ...

Noise from the ambient environment can introduce errors into the data during digital data transmissions. This noise can come from many different sources, including electromagnetic interference (EMI) ...

The US Food and Drug Administration (FDA) has issued four warning letters to companies in China, India, and the US for various violations of good manufacturing practices (GMPs) related to the ...

Data governance is transforming the world of business and IT as organizations increasingly acknowledge and embrace the importance of data in the modern world. And this transformation significantly ...

Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...

Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...

Precisely, a global leader in data integrity, is introducing new Data Quality, Data Enrichment, and Location Intelligence agents for the Precisely Data Integrity Suite. Working in coordination with ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...

The US Food and Drug Administration (FDA) has issued a draft guidance outlining how manufacturers can ensure the data integrity of bioavailability (BA) and bioequivalence (BE) studies to support ...